(PharmaNewsWire.Com, April 25, 2017 ) Middle-East and Africa Nuclear Medicine Radiopharmaceuticals Market research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 22.11% USD $1340 million by 2021, from USD $495 million in 2016.
Nuclear medicine uses a few portions of radioactive particles called radiotracers which are commonly inserted into the bloodstream, puffed or consumed. The radiotracer passes through the area which is being tested and gives out energy in the form of gamma rays which is detected via special camera and a computer which forms images of the internal body.
Radiopharmaceutical is a drug which is used for diagnostics or therapeutics. It comprises of a radioisotope bond to an organic molecule. This organic molecule transmits the radioisotope to certain organs, cells or tissues. In many diagnostic centres, nuclear medicine images can be overlapped with computed tomography or magnetic resonance imaging for special views which is known as image fusion. For more decisive information and diagnosis, views permit the information from two different examinations to be correlated and explained in one image. Imaging market is emerging but MRI/PET is not readily available at present.
Key factors which affect and thereby shift the market dynamics are studied intrinsically and are presented in an illustrious way in the report. Some of those factors are Increasing usage of SPECT and PET for scanning. Increasing cancer and cardiac diseases. Advancements in immunotherapy-based targeted for cancer treatment. Advances made for radiotracers. Rising number of diagnostic imaging techniques Half-life of radiopharmaceuticals is short. Stringent Government Regulations
For granular level understanding the nuclear medicine radiopharmaceuticals Market is segmented based on type and application, each being provided with Market Size Estimations and Y-o-Y Forecasts.
Based on Type: Diagnostic Radioisotopes: SPECT Technetium-99m Thallium-201 Gallium-67 Iodine-23 Others PET : Fluorine-18 Rubidium-82 Others
The Middle-East and Africa market is also analyzed individually in both the regions, thereby providing a more detailed geographical understanding of the market. Some of the major countries that hold significant place in this market include Egypt, Israel, KSA, UAE, Nigeria and Algeria.
Some of the key players that operate in the Middle-East and Africa Nuclear Medicine radiopharmaceuticals market include Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, GE Healthcare, Siemens Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Hologic Inc., Fujifilm Corporation, and Shimadzu Corporation.
The Middle-East and Africa Nuclear medicine radiopharmaceuticals market report offers wide-range of scope:
Regional level analysis that provides an individual perspective of Middle-East and Africa region individually and on a whole Know more about key areas of industry growth via detailed Segment-level analysis on basis of type and application along with market size forecasts and y-o-y estimations Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics Strategic Analyses containing PESTLE and Porters Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market For more reports related to the Pharmaceuticals Market: Global Anti-aging Market: http://www.marketdataforecast.com/market-reports/global-anti-aging-market-1398/
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit @ www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
